Vasodilator-stimulated phosphoprotein (VASP) is not a major mediator of platelet aggregation, thrombogenesis, haemostasis, and antiplatelet effect of prasugrel in rats-Reference-Cited by-同舟云学术

Vasodilator-stimulated phosphoprotein (VASP) is not a major mediator of platelet aggregation, thrombogenesis, haemostasis, and antiplatelet effect of prasugrel in rats

Published:2018-07-02 Issue:1 Volume:8 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Ito Yusuke,Ohno Kousaku,Morikawa Yuka,Tomizawa Atsuyuki,Mizuno Makoto,Sugidachi Atsuhiro

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-018-28181-8.pdf

Reference24 articles.

1. Members, W. G. et al. Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation. 133, e38–360 (2016).

2. Cimmino, G. et al. The complex puzzle underlying the pathophysiology of acute coronary syndromes: from molecular basis to clinical manifestations. Expert review of cardiovascular therapy 10, 1533–43 (2012).

3. Levine, G. N. et al. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery. Circulation 134, e123–55 (2016).

4. Jakubowski, J. A. et al. A comparison of the antiplatelet effects of prasugrel and high-dose clopidogrel as assessed by VASP-phosphorylation and light transmission aggregometry. Thrombosis and haemostasis 99, 215–22 (2008).

5. Gremmel, T. et al. Synergistic Inhibition of Both P2Y1 and P2Y12 Adenosine Diphosphate Receptors As Novel Approach to Rapidly Attenuate Platelet-Mediated Thrombosis. Arteriosclerosis, thrombosis, and vascular biology 36, 501–9 (2016).

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The vasodilator-stimulated phosphoprotein (VASP) supports the conduction of vasodilator signals and NO-induced arteriolar dilations in murine arteriolesin vivo;2023-03-20

2. Serum-integrated omics reveal the host response landscape for severe pediatric community-acquired pneumonia;Critical Care;2023-03-01

3. ALTERATION IN THROMBOGENIC PARAMETERS AS A POTENTIAL RAMIFICATION OF HIGH ALTITUDE INFLUENCE ON INDIVIDUALS;InterConf;2022-07-20

4. Platelet reactivity testing in peripheral artery disease;American Journal of Health-System Pharmacy;2022-04-05

5. The Function and Regulation of Platelet P2Y12 Receptor;Cardiovascular Drugs and Therapy;2021-07-28